109 103

Cited 0 times in

Changes of telomerase activity and proliferation by inhibition of reverse transcriptase activity in human cancer cell.

DC FieldValueLanguage
dc.contributor.author김준명-
dc.contributor.author라선영-
dc.contributor.author정현철-
dc.date.accessioned2016-05-16T11:08:47Z-
dc.date.available2016-05-16T11:08:47Z-
dc.date.issued2002-
dc.identifier.issn1598-2998-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/143891-
dc.description.abstractPurpose: Activation of telomerase is proposed to be an essential step in cancer cell immortalization and cancer progression. 3'-azido-2',3'-dideoxythymidine (AZT), a reverse transcriptase inhibitor, was reported to be incorporated in telomeric sequences of immortalized cells in culture and to suppress the activity of telomerase and the cell proliferation. In this study, after induction of cancer cell senescence with long-term treatment of AZT, we investigated the dynamics of telomerase subunits (hTERT, hTR, TEP), transcription factors (c-Myc, Mad1), telomerase activity, and finally, telomere length in a human breast cancer cell line. Materials and Methods: Human breast cancer cell (MDA-MB-231) was treated with AZT. Senescence was measured by senescence-associated β-gal staining and apoptosis was counted by dTd enzyme assay. Telomerase activity (by TRAP assay), expression of telomerase subunit genes (by RT-PCR and real-time PCR) and telomere length (by Southern blot analysis) were measured after the AZT treatment. Results: We found evidences of senescence, apoptosis and growth delay after AZT treatment. In addition, AZT- treated cancer cells showed inhibition of telomerase activity and shortening of telomere length in a dose- and duration-dependent way. Among the telomerase subunits, hTERT and c-Myc were the first factors to change after AZT treatment, subsequently, followed by the changes of hTR, Mad1 and TEP. Conclusion: The suppression of hTERT and c-Myc by AZT treatment was the initial genetic phenomenon, subsequently followed by the changes of hTR, Mad1 and TEP.-
dc.description.statementOfResponsibilityopen-
dc.format.extent223~233-
dc.relation.isPartOfCANCER RESEARCH AND TREATMENT-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleChanges of telomerase activity and proliferation by inhibition of reverse transcriptase activity in human cancer cell.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorHyun Jung Ji-
dc.contributor.googleauthorKyu Hyun Park-
dc.contributor.googleauthorTae Soo Kim-
dc.contributor.googleauthorSun Young Rha-
dc.contributor.googleauthorNae Choon Yoo-
dc.contributor.googleauthorJun Myung Kim-
dc.contributor.googleauthorJun Suk Kim-
dc.contributor.googleauthorJae Kyoung Roh-
dc.contributor.googleauthorWoo Ick Jang-
dc.contributor.googleauthorHyun Cheol Chung-
dc.identifier.doi10.4143/crt.2002.34.3.223-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00953-
dc.contributor.localIdA03773-
dc.contributor.localIdA01316-
dc.relation.journalcodeJ00453-
dc.identifier.eissn2005-9256-
dc.identifier.pmid26680867-
dc.subject.keywordReverse transcriptase inhibitor-
dc.subject.keywordSenescence-
dc.subject.keyword Telomerase-
dc.subject.keywordc-Myc-
dc.subject.keywordhTERT-
dc.contributor.alternativeNameKim, June Myung-
dc.contributor.alternativeNameRha, Sun Young-
dc.contributor.alternativeNameChung, Hyun Cheol-
dc.contributor.affiliatedAuthorKim, June Myung-
dc.contributor.affiliatedAuthorChung, Hyun Cheol-
dc.contributor.affiliatedAuthorRha, Sun Young-
dc.rights.accessRightsfree-
dc.citation.volume34-
dc.citation.number3-
dc.citation.startPage223-
dc.citation.endPage233-
dc.identifier.bibliographicCitationCANCER RESEARCH AND TREATMENT, Vol.34(3) : 223-233, 2002-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.